爆了！刚刚，直线拉涨停！

Market Overview - The pharmaceutical sector has shown strong performance, with stocks like Duori Pharmaceutical and Haichen Pharmaceutical hitting the daily limit up of 20% following the listing of Heng Rui Pharmaceutical, which saw its stock price surge over 30% on its debut [1][6][7] - The A-share market experienced a slight increase, with the Shanghai Composite Index rising by 0.08%, the Shenzhen Component Index by 0.44%, and the ChiNext Index by 0.37% [1] Pharmaceutical Sector Performance - Heng Rui Pharmaceutical's initial public offering (IPO) raised approximately HKD 9.7473 billion, with a subscription rate of 454.85 times for the Hong Kong public offering and 17.09 times for the international offering [6] - The stock price of Heng Rui Pharmaceutical reached a market capitalization of HKD 396 billion on its first trading day [5][6] - Other pharmaceutical stocks such as Duori Pharmaceutical and Haichen Pharmaceutical also experienced significant gains, contributing to the overall strength of the pharmaceutical sector [6][7] Automotive Sector Performance - The automotive sector showed active performance, with several stocks experiencing gains, including Xuelong Group and BYD, which rose by 9.98% and 2.63% respectively [10] - The narrow passenger car retail market is projected to reach approximately 1.85 million units this month, reflecting a year-on-year growth of 8.5% and a month-on-month increase of 5.4% [11] Future Outlook - According to Xiangcai Securities, the domestic innovative drug industry is expected to reach a turning point by 2025, shifting from capital-driven to profit-driven growth, indicating potential investment opportunities in the sector [8]